ICU Medical (NASDAQ:ICUI) Shares Gap Up – Still a Buy?

ICU Medical, Inc. (NASDAQ:ICUI)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $160.11, but opened at $167.49. ICU Medical shares last traded at $167.40, with a volume of 20,959 shares traded.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ICUI. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. KeyCorp lifted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, Raymond James boosted their price target on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, ICU Medical has an average rating of “Moderate Buy” and a consensus target price of $177.25.

ICU Medical Trading Down 0.4 %

The stock has a fifty day simple moving average of $171.48 and a 200 day simple moving average of $150.56. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Insider Buying and Selling

In other news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 40,364 shares of company stock worth $6,869,878. 6.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On ICU Medical

A number of institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp increased its position in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after acquiring an additional 77,506 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after purchasing an additional 48,106 shares during the period. Dimensional Fund Advisors LP grew its holdings in ICU Medical by 21.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock valued at $36,996,000 after purchasing an additional 55,588 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in ICU Medical by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after purchasing an additional 27,927 shares during the period. Finally, WCM Investment Management LLC lifted its stake in ICU Medical by 1.3% in the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock worth $45,272,000 after purchasing an additional 3,407 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.